LINC01298

Across TCGA pan-cancer cohorts, LINC01298 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01298 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC01298 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01298 expression acts as an unfavorable survival marker, although some lineages such as GBM and SKCM show a favorable association.

UCS, CESC, and CHOL are the cancer types where LINC01298 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.237	0.713	<.001	144	view →
CESC	DFS	Tertile	III,IV	0.531	0.779	.012	60	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	54	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
UCEC	DFS	Tertile	All	0.804	0.903	.018	36	view →
LIHC	DFS	Tertile	All	0.157	0.540	.001	30	view →
GBM	DFS	Tertile	All	0.323	0.175	.016	18	view →
LUAD	DFS	Tertile	IV	0.107	0.667	<.001	18	view →
LGG	OS	Tertile	All	0.237	0.465	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01298–UCS (OS)

Open the UCS breakdown →